Metraipolis › archive › dc_eccbe8924c1d

Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors — Europe PMC PMID:42369076

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42369076
DOI
10.1155/srat/6411721
License (as archived)
solo-consultazione
Archived
2026-10-19T00:26:34.380Z
SHA-256 of the archived text
abf1e933d08487ce9d6f5df7c9232720e0b86dbb08f64e7d57ec46ee57913769
Stable URL of this page
https://metraipolis.com/documento/dc_eccbe8924c1d

How to cite

Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors — Europe PMC PMID:42369076 — Europe PMC (en), https://europepmc.org/article/MED/42369076 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eccbe8924c1d (Metraipolis archive dc_eccbe8924c1d, sha256 abf1e933d08487ce9d6f5df7c9232720e0b86dbb08f64e7d57ec46ee57913769)
BibTeX
@misc{dceccbe8924c1d,
  title = {Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors — Europe PMC PMID:42369076},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42369076},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eccbe8924c1d; sha256 abf1e933d08487ce9d6f5df7c9232720e0b86dbb08f64e7d57ec46ee57913769},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42369076. Agents can read the archived copy with the MCP tool read_document.